Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia ; volume:238 ; number:10 ; day:20 ; month:8 ; year:2021 ; pages:2693-2708 ; date:10.2021
Psychopharmacology ; 238, Heft 10 (20.8.2021), 2693-2708, 10.2021
- Creator
-
Roch, Catherine
Bergamini, Giorgio
Steiner, Michel A.
Clozel, Martine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-021-05954-0
- URN
-
urn:nbn:de:101:1-2021112918065891089791
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roch, Catherine
- Bergamini, Giorgio
- Steiner, Michel A.
- Clozel, Martine
- SpringerLink (Online service)
Other Objects (12)
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Daridorexant bei chronischer Insomnie : der duale Orexin-Rezeptor-Antagonist als Therapieoption ohne zeitliche Einschränkung bei der langfristigen Verordnung
Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Daridorexant bei chronischer Insomnie : der duale Orexin-Rezeptor-Antagonist als Therapieoption ohne zeitliche Einschränkung bei der langfristigen Verordnung
Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Daridorexant bei chronischer Insomnie : der duale Orexin-Rezeptor-Antagonist als Therapieoption ohne zeitliche Einschränkung bei der langfristigen Verordnung
Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist